Zimmer Biomet ZBH
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Zimmer Biomet (ZBH) Business Model and Operations Summary
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Key Insights
Zimmer Biomet (ZBH) Core Market Data and Business Metrics
Latest Closing Price
$113.18Market Cap
$22.35 BillionPrice-Earnings Ratio
25.55Total Outstanding Shares
199.06 Million SharesTotal Employees
17,000Dividend
$0.24 Per Share QuarterlyIPO Date
August 7, 2001SIC Description
Orthopedic, Prosthetic & Surgical Appliances & SuppliesPrimary Exchange
New York Stock ExchangeHeadquarters
345 East Main Street, Warsaw, IN, 46580
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow | $126.80 Million |
| Net Cash Flow From Investing Activities, Discontinued | $0 |
| Net Cash Flow From Investing Activities | $-888.10 Million |
| Net Cash Flow From Financing Activities | $-484.50 Million |
| Net Cash Flow, Discontinued | $0 |
| Net Cash Flow From Operating Activities, Continuing | $1.50 Billion |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Cost Of Revenue | $2.19 Billion |
| Basic Average Shares | $203.10 Million |
| Preferred Stock Dividends And Other Adjustments | $0 |
| Net Income/Loss Available To Common Stockholders, Basic | $903.80 Million |
| Income Tax Expense/Benefit, Deferred | $-47.70 Million |
| Benefits Costs and Expenses | $6.64 Billion |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Other Comprehensive Income/Loss Attributable To Parent | $-71.80 Million |
| Other Comprehensive Income/Loss | $-71.80 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss Attributable To Parent | $832 Million |
| Comprehensive Income/Loss | $832 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Other Current Assets | $2.44 Billion |
| Other Non-current Assets | $10.05 Billion |
| Noncurrent Assets | $16.69 Billion |
| Liabilities And Equity | $21.37 Billion |
| Equity | $12.48 Billion |
| Current Liabilities | $2.45 Billion |
Historical Dividends
Current dividend: $0.24 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 26, 2025 | Apr 30, 2025 | Mar 31, 2025 | $0.24 | Quarterly |
| Dec 18, 2024 | Jan 31, 2025 | Dec 30, 2024 | $0.24 | Quarterly |
| Aug 29, 2024 | Oct 31, 2024 | Sep 30, 2024 | $0.24 | Quarterly |
| May 13, 2024 | Jul 31, 2024 | Jun 26, 2024 | $0.24 | Quarterly |
| Feb 21, 2024 | Apr 30, 2024 | Mar 29, 2024 | $0.24 | Quarterly |
| Dec 14, 2023 | Jan 31, 2024 | Dec 27, 2023 | $0.24 | Quarterly |